US FDA Takes Steps To Simplify Combo Product Consultations
This article was originally published in Clinica
Executive Summary
The US FDA says it is already simplifying access to its IT system, revising SOPs, updating its organizational charts and putting out more guidance documents, as recommended in an internal assessment (PDF) of its inter-center consultation process for combination products that was released by the agency Oct. 14.